Introduction {#sec1}
============

α-[l]{.smallcaps}-Rhamnosidases (E.C. 3.2.1.40) are ubiquitous enzymes in nature and are responsible for the removal of the α-[l]{.smallcaps}-rhamnose (α-[l]{.smallcaps}-Rha) entity from various glycoconjugates. Indeed, α-[l]{.smallcaps}-Rha is widely distributed in plants and bacteria as polysaccharide residue (pectins, *O*-antigen of pathogenic bacteria) in glycosylated derivatives (flavonoids and terpenes) or biosurfactants (rhamnolipids).^[@ref1]^ The α-[l]{.smallcaps}-Rha motif is, in addition, widely found in surface glycoproteins of bacteria and therefore participates in the virulence of the pathogen. Conversely, it is rarely described to form a direct bond with an amino acid (unlike glucose, mannose, galactose, \...) because, at present, only few examples refer to this type of rare glycosylation.^[@ref2]^ Since many years, rhamnosidases have also been used as biocatalysts in numerous industrial processes. In the food industry, they have been used for production of fruit juice or for the improvement of wine aroma by deglycosylation of terpenes. Thus, α-[l]{.smallcaps}-Rha products can be directly valorized in the chemical industry as chiral precursors in synthesis or for the glycodiversification of products.^[@ref3]^ α-[l]{.smallcaps}-Rhamnosidases are also widely exploited in the pharmaceutical industry for flavonoid derhamnosylation (see [Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}). Indeed, these compounds are recognized for their beneficial effects on health in humans, and it has been shown that monoglycosylated compounds have better bioavailability than their disaccharide analogues.^[@ref4],[@ref5]^ For example, (1) prunin, the derhamnosylated product of **1** or **2**, was recently described to have a strong effect on the inhibition of enzyme systems related to diabetes;^[@ref6]^ (2) diosmetin 7-*O*-glucoside (from **3** and **4**) was reported to have cardiovascular and hepatoprotective effects, as well as antioxidant, antiarrhythmic, and anticomplementay activities;^[@ref7]^ (3) quercetin 7-*O*-glucopyranoside (from **5** and **6**) has demonstrated its potency in inhibiting the viral RNA polymerase from influenza A and B viruses;^[@ref8]^ and (4) hesperetin 7-*O*-glucoside (from **7** and **8**) has been shown to inhibit the growth of *Helicobacter pylori*, a causative agent for gastric diseases.^[@ref9]^ Unfortunately, the majority of them have a low occurrence in nature or are difficult to isolate from plant sources, and their chemical syntheses remain tedious, with all consequences leading to expensive natural compounds.

![Natural glycosylated flavonoids used as substrates in this study.](ao-2018-03186y_0005){#fig1}

All reported α-[l]{.smallcaps}-rhamnosidases act following a mechanism of inversion of configuration, and they are listed in three CAZy glycoside hydrolase (GH) families (GH28, GH78 and GH106, <http://www.cazy.org>/, accessed November 2018).^[@ref10]^ Unlike GH28 and GH106 families containing α-[l]{.smallcaps}-rhamnosidases that are involved in pectin metabolism, GH78 family is composed of α-[l]{.smallcaps}-rhamnosidases exhibiting valuable activities in natural product synthesis. Indeed, several characterized GH78 α-[l]{.smallcaps}-rhamnosidases have been demonstrated to catalyze the hydrolysis of rhamnosides bound to flavonoid glucosides with a wide diversity of linkage regioselectivity on the glucose: α(1 → 2), α(1 → 6), and more rarely, α(1 → 3).^[@ref11]−[@ref16]^ However, if some differences in bond selectivity for hydrolysis were reported in these studies, then no rational understanding of such substrate specificity could be analyzed. This was likely due to the small number of four GH78 structures that are currently available in the Protein Data Bank. The corresponding proteins have been isolated from *Bacillus* sp. GL1,^[@ref1]^*Bacteroides thetaiotaomicron*,^[@ref15]^*Streptomyces avermitilis*,^[@ref17]^ and *Klebsiella oxytoca*.^[@ref18]^

With the objective of using of α-[l]{.smallcaps}-rhamnosidases as industrial biocatalysts, thermostability is highly advantageous and looked for because it is correlated with a higher resistance of the enzyme toward increased incubation time and temperature, as well as a higher tolerance to nonaqueous solvents. However, few of the characterized ones are from thermophilic microorganisms: *Thermomicrobium* sp. (RhmA and RhmB),^[@ref19]^*Clostridium stercorarium* (RamA),^[@ref15]^ and *Aspergillus terreus*.^[@ref5]^ In this context, we have identified a thermophilic bacteria, *Dictyoglomus thermophilum*,^[@ref20],[@ref21]^ which possesses a single gene on its genome, *dicth_0289*, coding for potential exo-α-[l]{.smallcaps}-rhamnosidase. The corresponding enzyme *Dt*Rha identified by B5YC64 (UniProt identification) has a sequence identity of 35% with the crystallized one from *S. avermitilis* (3W5M, PDB identification).

In the course of our ongoing research devoted to the discovery of original and robust biocatalysts for the chemoenzymatic synthesis of natural compounds,^[@ref22]−[@ref24]^ we thus got interested in the cloning, overexpression, and purification of this thermophilic *Dt*Rha. Owing to enzymology, 3D structure determination using X-ray diffraction, and modeling experiments, we were able to show the substrate versatility of this α-[l]{.smallcaps}-rhamnosidase and to fully demonstrate the requirement for its efficient recognition of glycosylated flavonoid. These experiments led to the development of a cheap and easy access to very expensive flavonoids such as prunin, diosmetin, or hesperetin 7-*O*-glucopyranoside.

Results and Discussion {#sec2}
======================

Gene Cloning and Protein Overexpression {#sec2.1}
---------------------------------------

The 2763 bp *dicth_0289* gene was amplified from *D. thermophilum* genomic DNA from the constructed primers to allow insertion between the *Nhe*I/*Sal*I restriction sites of the vector pET28-a(+). The corresponding recombinant plasmid was transformed in *E. coli* Rosetta-(DE3), and the protein was expressed after isopropyl β-[d]{.smallcaps}-1-thiogalactopyranoside (IPTG) induction of the bacterial culture in the nutrient medium LB/Kan/Cam at 37 °C for 20 h. After lysis, thermal clarification, and purification on a Ni-NTA column, the purified enzyme was analyzed on 1D 10% SDS-PAGE gel ([Figure S1](http://pubs.acs.org/doi/suppl/10.1021/acsomega.8b03186/suppl_file/ao8b03186_si_001.pdf)). The protein consists of a sequence of 921 acids that represents a theoretical molecular weight of 106 kDa, with the presence of six His motifs (from His-tag), and gel analysis confirmed the purity of the protein because a single band was observed at the level of the 100 kDa reference protein band. The production yield of the protein *Dt*Rha is 4.5 mg/L bacterial culture.

Biochemical Characterization of *Dt*Rha {#sec2.2}
---------------------------------------

Purified *Dt*Rha enzyme was further used to assess its catalytic activity. The kinetic parameters were evaluated by monitoring the hydrolytic activity of the enzyme toward 20 different *p*-nitrophenyl-sugars (pNP-sugars, [Figure S2](http://pubs.acs.org/doi/suppl/10.1021/acsomega.8b03186/suppl_file/ao8b03186_si_001.pdf)). Potentially cleaved pNP could be easily quantified at 405 nm. Among them, only pNP-α-[l]{.smallcaps}-Rha demonstrated to be a substrate, thus confirming the unique carbohydrate specificity of *Dt*Rha. The values of optimum pH and temperature were determined to be 5.0 and 95 °C, respectively (see [Figure S3](http://pubs.acs.org/doi/suppl/10.1021/acsomega.8b03186/suppl_file/ao8b03186_si_001.pdf)). Indeed, the enzymatic activity is favored for a large range of acidic pH between 4.0 and 7.0, as similarly demonstrated for previously reported α-[l]{.smallcaps}-rhamnosidases.^[@ref5],[@ref15]^ The Michaelis--Menten parameters were thus determined at pH 5.0 and at 37 °C. Under these conditions, the *K*~M~ value was evaluated at 54.00 ± 0.03 μM and the *k*~cat~ one at 0.17 ± 0.01 s^--1^ ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"} and [Figure S4](http://pubs.acs.org/doi/suppl/10.1021/acsomega.8b03186/suppl_file/ao8b03186_si_001.pdf)). Compared to other recombinant α-[l]{.smallcaps}-rhamnosidases from the GH78 family, *Dt*Rha is one of the best enzymes for the recognition of pNP-α-[l]{.smallcaps}-Rha but catalyzes its conversion very slowly at 37 °C (indeed, its relative activity is 17% compared to that at 90 °C). However, a poor activity on unnatural aryl rhamnosides is a not a predictor at all for its enzymatic activity on rhamnosyl flavonoids, as demonstrated by Grandits et al.^[@ref25]^*Dt*Rha is also proven to be very tolerant to a variety of solvent mixtures (CH~3~CN, DMSO, and DMF), especially to 30 % aqueous MeOH, in which the enzyme kept up to 50% of its activity (see [Figure S5](http://pubs.acs.org/doi/suppl/10.1021/acsomega.8b03186/suppl_file/ao8b03186_si_001.pdf)). All these parameters are compatible with efficient biocatalyzed synthesis and encouraged us to probe the hydrolytic properties of *Dt*Rha on natural flavonoids.

###### Kinetic Parameters for Recombinant α-[l]{.smallcaps}-Rhamnosidases from GH78 Family toward the Aryl Rhamnoside pNP-α-[l]{.smallcaps}-Rha and Their Relative Hydrolytic Activity toward α(1 → 2)- or α(1 → 6)-Bound Rhamnose to Glucose in Several Flavonoids[a](#t1fn1){ref-type="table-fn"}

  α-[l]{.smallcaps}-rhamnosidase   *K*~M~ (mM)   *k*~cat~ (s^--1^)   *k*~cat~/*K*~M~ (s^--1^ mM^--1^)   1,2-flavonoids   1,6-flavonoids
  -------------------------------- ------------- ------------------- ---------------------------------- ---------------- ----------------
  RhaB^[@ref1]^                    0.28          140                 500                                \+               \+
  *Ko*Rha^[@ref18]^                0.21          0.98                4.7                                n.d.             n.d.
  *Sa*Rha^[@ref17]^                0.03          26.4                880                                \+               \+
  RhmA^[@ref19]^                   0.46          460                 1000                               ++               \+
  RhmB^[@ref19]^                   0.66          1254                1900                               \+               \+
  *Bt*Rha^[@ref26]^                2.87          1743                607                                \+               ++
  *Dt*Rha                          0.054         0.17                3.1                                                  

Plus sign (+) indicates the level of detected activity when comparing values for the same enzyme; n.d.: not determined.

Determination of the Substrate Specificity {#sec2.3}
------------------------------------------

α-[l]{.smallcaps}-Rhamnosidases from GH78 family are well described for their potency to remove α-[l]{.smallcaps}-Rha from flavonoids (see, for example, [Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}). However, in the vast majority of the previously published studies, the aglycone part of the flavonoids was not the same, and it thus remains difficult to compare the α(1 → 2) and/or α(1 → 6) selectivity of the different enzymes on similar natural molecules. Here, we were thus encouraged, for the first time, to systematically probe *Dt*Rha for its α(1 → 2) and/or α(1 → 6) selectivity using flavanone ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}, **1** and **2**), flavone ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}, **3** and **4**) and isoflavonoid ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}, **5** to **8**) aglycones. Results of the catalyzed hydrolysis for two different concentrations of *Dt*Rha are summarized in [Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}. At low concentration, it is noteworthy that α(1 → 2)-rhamnosylated flavonoids (neohesperidosides) demonstrated to be more efficient substrates than their α(1 → 6) counterparts (rutinosides), whatever the aglycone moiety. Moreover, at slightly increased concentration of *Dt*Rha, naringin **1** and neoeriocitrin **5** were the most efficiently transformed, with a conversion rate higher than 95% in 3 h under our reaction conditions. On the contrary, even in the case of 10 times higher *Dt*Rha concentration, conversion rates were limited to 40% for α(1 → 6) derivatives. Therefore, *Dt*Rha is specific to α(1 → 2) glycosidic linkage rather than α(1 → 6) linkage, with ratio going up to 4 in terms of conversion rate. In addition, the aglycone part still seems to have an influence on the recognition and velocity of the enzyme, with the flavonone of narigin **1** being preferred. Flavonoids containing methoxy groups on their aromatic rings were the less favored substrates (see compounds **3**, **4**, **7**, and **8**) compared to phenol derivatives (**1**, **2**, **5**, and **6**). Therefore, the enzymatic preferences in terms of aglycons are in this decreasing order: flavanone, isoflavonoid (phenol group), flavone, and isoflavonoid.

###### Conversion Rate of the Derhamnosylation of Natural Flavonoids Catalyzed by *Dt*Rha[a](#t2fn1){ref-type="table-fn"}

![](ao-2018-03186y_0002){#gr4}

  α(1 → 2)-rhamnosylated flavonoid   α(1 → 6)-rhamnosylated flavonoid                        
  ---------------------------------- ---------------------------------- ------ ------- ----- ------
  **1**                              44.1                               97.6   **2**   8.5   39.4
  **3**                              18.1                               67.9   **4**   0     24.9
  **5**                              6.2                                96.1   **6**   2.1   22.1
  **7**                              19.9                               58.6   **8**   6.0   14.5

Reactions were performed according to conditions described in [Experimental Procedures](#sec4){ref-type="other"} and analyzed by reverse-phase HPLC to quantify the conversion rate (percentage of substrate hydrolyzed by *Dt*Rha) ([Figures S6--S13](http://pubs.acs.org/doi/suppl/10.1021/acsomega.8b03186/suppl_file/ao8b03186_si_001.pdf)), and products were characterized by HRMS ([Figures S14--S17](http://pubs.acs.org/doi/suppl/10.1021/acsomega.8b03186/suppl_file/ao8b03186_si_001.pdf)).

Resolution of the 3D Structure of *Dt*Rha {#sec2.4}
-----------------------------------------

Crystals of *Dt*Rha suitable for diffraction were obtained with 30% PEG 1500 using sitting drop vapor diffusion. The structure was refined to 2.7 Å using α-[l]{.smallcaps}-rhamnosidase *Sa*Rha from *S. avermitilis* (PDB 3W5M) as the replacement model.^[@ref17]^ Two protein monomers are visible in the asymmetric crystal unit. However, according to PISA server analysis,^[@ref27]^*Dt*Rha is a single monomer, which is supported by size-exclusion chromatography analysis (data not shown). The overall structure of *Dt*Rha is similar to those observed for some other reported GH78 α-[l]{.smallcaps}-rhamnosidases: *Sa*Rha from *S. avermitilis* (PDB 3W5M and 3W5N)^[@ref17]^ and RhaB from *Bacillus* sp. GL1 (PDB 2OKX)^[@ref1]^ and *B. thetaiotaomicron* (3CIH). *Dt*Rha is composed of five distinct domains, namely, domain N (1--125), domain E (126--317), domain F (348--437), catalytic domain A (438--813), and domain C (814--921). The loop 658--694 could not be refined because of poor electronic density. When aligning the putative *Dt*Rha active site to the *Sa*Rha active site, most residues surrounding the active site are conserved, especially the catalytic residues, namely, the catalytic acid E479 (E636 in *Sa*Rha) and the catalytic base E782 (E895 in *Sa*Rha) ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}).

![(A) Overall fold of *Dt*Rha. The two catalytic residues are indicated by arrows. (B) Superimposition of active sites of *Dt*Rha and SaRha78 from *S. avermitilis*. Residues are respectively colored in orange and gray. Numbers indicate the residue from *Dt*Rha and the corresponding residues from SaRha78.](ao-2018-03186y_0004){#fig2}

Docking of Rhamnosylated Flavonoids in *Dt*Rha Active Site {#sec2.5}
----------------------------------------------------------

Using the *Dt*Rha crystal structure as a starting model, the missing 658--694 loop was rebuilt by several cycles of molecular dynamics, followed by energy minimization. Once a full *Dt*Rha model was available, three ligands were chosen to identify the structural interactions that lead to differences in enzymatic activity. Naringin **1** was chosen as a representative efficient substrate, bearing a neohesperidose glycan unit containing an α(1 → 2)-linked rhamnose on a naringenin aglycon moiety. Narirutin **2**, bearing the same aglycon---but linked to rutinose disaccharide---exhibiting an α(1 → 6)-linked rhamnose, was also chosen a weak substrate. Eriocitrin **6**, a quasi-ineffective substrate in low enzymatic concentration, also bearing a rutinoside moiety on eryodictyol aglycon, was selected in docking analyses. All three substrates were docked using soft-restrained molecular dynamics, as previously reported for other enzymes,^[@ref28]−[@ref30]^ and minimized final snapshots are depicted in [Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}. Narirutin and eriocitrin exhibited similar interactions in the active site, involving some H-bonding between rhamnoside hydroxyls O2 and O3 with carboxylic residues (namely, D473, E479, and E782). On the other hand, naringin is tightly bound to the *Dt*Rha active site. Rhamnose O3 is H-bonded to NE~1~ from W538, and O2 is H-bonded to D473, R477, and E782. The latter residue also bridges O3 from the glucoside moiety, strongly stabilizing the disaccharide in the active site. Two other stabilizing H-bonds between R783 and O3 and O4 from glucose are visible, which strongly increase the stabilization of the complex. Finally, the aglycon conformation enables the H-bond between the hydroxyl and the Y587 residue and π-stacking between F144 and the aromatic ring of the naringin. These differences in H-bond networks between naringin and narirutin (as well as eriocitrin) can be explained by the nature of the glycosidic bond between rhamnose and glucose. In other words, neohesperidoside conformation helps to interact with the *Dt*Rha active site, whereas rutinoside does not provide a conformation that leads to H-bonds. A similar analysis based on molecular dynamics and computational studies on Ram2 α-[l]{.smallcaps}-rhamnosidase from *Pediococcus acidilactici* was used to demonstrate the peculiar specificity of this enzyme for rhamnose-bound glucose compared to aryl aglycons such as pNP-α-[l]{.smallcaps}-Rha, correlated to a difference in substrate binding and orientation in the active site.^[@ref25]^

![(A--C) Conformations of rhamnosylated substrates bound to the *Dt*Rha active site and interactions with active site residues: (A) naringin, (B) narirutin, and (C) superimposition of two docked substrate conformations. The *Dt*Rha active site is rendered as a solvent-accessible surface.](ao-2018-03186y_0003){#fig3}

Conclusions {#sec3}
===========

The search for efficient, thermostable, and robust biocatalysts is still an ongoing quest in the biotechnological field for numerous industrial applications. An original α-[l]{.smallcaps}-rhamnosidase was cloned from *D. thermophilum* and purified to homogeneity with good yields. It proved to be very efficient up to 90 °C and in complex solvents' mixture. Despite its moderate efficiency toward the hydrolysis of pNP-α-[l]{.smallcaps}-Rha, we were able to demonstrate its advantage for the enzymatic synthesis of expensive and natural compounds with biological properties. Of tremendous interest, for the first time, we report here, to our knowledge, the structural requirements that explain why *Dt*Rha possesses an α(1 → 2) toward α(1 → 6) preference during the hydrolysis of α-[l]{.smallcaps}-Rha from flavonoids. In addition, this particular enzyme proves to be very versatile toward the aglycone moiety. Besides these fundamental observations, such enzymatic properties of *Dt*Rha pave the way for the industrial development of high-scale preparation of prunin, diosmetin, or hesperetin 7-*O*-glucopyranoside.

Experimental Procedures {#sec4}
=======================

Materials {#sec4.1}
---------

All *p*-nitrophenyl monosaccharides (pNP-sugars) were purchased from Carbosynth (Compton, U.K.). All chemicals used were of analytical reagent grade. Phusion High-Fidelity DNA polymerase was purchased from Thermo Fisher and pET-28a(+) from Novagen.

*Dt*Rha Cloning, Expression, and Purification {#sec4.2}
---------------------------------------------

The open reading frame encoding *Dt*Rha (DICTH_0289) was amplified from *D. thermophilum* DSM 3960 genomic DNA (DSMZ Institute, Germany) by PCR using Phusion High-Fidelity DNA polymerase (Thermo Fisher) using the following primers: 5′-tt[gctagc]{.ul}atgaagtcaagtaatatttactcaccctt-3′ and 5′-tt[gtcgac]{.ul}ttatatcttttccatataaaagttgtatgatcc-3′. These primers respectively enabled the insertion of *Nhe*I and *Sal*I restriction sites up- and downstream of the gene. After enzymatic digestion, PCR amplicon was directly ligated into pET-28a(+) vector using T4 DNA Ligase (Rapid DNA ligation kit, Fermentas), and the final construct pDtRha-28 was transformed in *E. coli* DH5α for amplification. pDtRha-28 plasmid was then transformed in Rosetta(DE3) expression strain. After selection on antibiotics, a single colony of transformed cells was used to inoculate LB broth medium containing the appropriate antibiotics. Cells were grown at 37 °C with 250 rpm shaking until OD~600~ reached 0.6, and IPTG (200 μM final concentration) was added before overnight incubation at 37 °C. Cells were harvested, resuspended in lysis buffer (50 mM Tris (pH 8.0), 200 mM NaCl, and 0.1% Triton X-100), incubated with lysozyme (0.1 mg/mL) at 4 °C for 20 min, and lysed by several freeze--thaw cycles, followed by ultrasonication. After the centrifugation step (32,000*g* for 20 min), clarification of supernatant was carried out by heat treatment (15 min at 70 °C) to remove nonthermostable proteins. Final centrifugation (32,000*g* for 20 min) was done, and supernatant was used for chemoenzymatic synthesis.

Enzyme Activity Assays {#sec4.3}
----------------------

*Dt*Rha activity was assayed at 37 °C in 200 μL reaction mixtures containing substrates (0.01--10 mM), 0.425 μg enzyme, and Tris buffer (200 mM, pH 6.0). Residual spontaneous hydrolysis of the substrate was determined on a sample containing H~2~O instead of enzyme. For *p*-nitrophenol (pNP)-containing substrates, after 30 min reaction, 100 μL sodium carbonate (1 M) was added, and produced pNP was quantified by absorbance measurement at 405 nm. All kinetics parameters were calculated by fitting of saturation curves (as the mean of triplicate measurements) with standard Michaelis--Menten equation using Prism 6 (GraphPad).

Effect of pH and Temperature on *Dt*Rha Activity {#sec4.4}
------------------------------------------------

The optimum pH for *Dt*Rha was determined by measuring pNP-α-[l]{.smallcaps}-Rha hydrolysis under several pH values ranging from pH 4.0 to 10.0. The buffers used were as follows: acid citric/sodium phosphate buffer (200 mM) for pH 4.0 to 6.0, imidazole/HCl buffer (200 mM) for pH 7.0, Tris/HCl buffer (200 mM) for pH 8.0, tris base buffer (200 mM) for pH 9.0, and sodium carbonate buffer (200 mM) for pH 10.0. One hundred microliter samples containing 1 mM pNP-α-[l]{.smallcaps}-Rha, 10 μL buffer, and 5 μL diluted *Dt*Rha were incubated for 5 min at 37 °C. Then, reactions were quenched by adding 50 μL Na~2~CO~3~ (1 M), and absorbance was measured at 405 nm. The dependence of the enzyme activity on temperature was determined by measuring the hydrolysis of pNP-α-[l]{.smallcaps}-Rha for several temperatures ranging from 40 to 100 °C. Samples were prepared following the same protocol as the pH dependence study but only in 20 mM imidazole-HCl buffer at pH 6.0. After 5 min incubation, reaction was quenched by adding 50 μL Na~2~CO~3~ (1 M), and relative activity was calculated according to absorbance measured for each temperature at 405 nm.

Substrate Specificity of Recombinant α-[l]{.smallcaps}-Rhamnosidase *Dt*Rha {#sec4.5}
---------------------------------------------------------------------------

An assay mixture composed of 100 μL citric acid-sodium phosphate buffer (0.1 M, pH 6.0), 1 mM substrate, and 0.05 mg/mL *Dt*Rha was heated at 50 °C. At respective times, the reaction mixture was subjected to HPLC analysis after filtration through a 0.22 μm filter. An Agilent 1220 Infinity II LC coupled with an Agilent Zorbax Eclipse XDB-C18 column (4.6 × 150 mm, 3.5 μm) and a diode array detector (DAD) was used to determine the concentrations of the substrates and products. Following an injection of 20 μL, the column was eluted with a gradient elution at 30 °C and kept the flow rate at 0.8 mL/min. The mobile phase was composed of H~2~O/0.1% TFA (A) and CH~3~CN/0.1% TFA (B). The gradient procedure began with A/B = 90:10 within 0--4 min. This procedure was followed by a linear change to A/B = 20:80 within 4--23 min, maintaining A/B = 20:80 within 23--24 min, and then a linear return to A/B = 90:10 within 24--30 min. The target compounds were captured in DAD at 280 nm, and samples were analyzed by HRMS.

*Dt*Rha Crystallogenesis and Structure Determination {#sec4.6}
----------------------------------------------------

*Dt*Rha was further purified by immobilized metal-affinity chromatography (IMAC) and gel filtration before being concentrated in 20 mM Tris at 10 mg/mL before being used for crystallogenesis assays. Crystals suitable for diffraction were obtained by sitting drop vapor diffusion when using 30% PEG 1500 as the crystallization agent. Crystals were cryprotected using 25% methylpentane-2,4-diol before been frozen in liquid nitrogen. Data were collected on beamline Proxima-1 at Soleil Synchrotron Facility, integrated, reduced, and scaled with the X-Ray Detector Software (XDS).^[@ref31]^*S. avermitilis* α-[l]{.smallcaps}-rhamnosidase (PDB 3W5M)^[@ref17]^ was then used as a template for molecular replacement using the PHASER program.^[@ref32]^ Refinement and model building were conducted using Phenix^[@ref33]^ and COOT.^[@ref34]^ Model quality was assessed at every refinement step using MolProbity.^[@ref35]^ The structure of *Dt*Rha was deposited to the Protein Data Bank (PDB code 6I60). Data and final refinement statistics are listed in [Table S1](http://pubs.acs.org/doi/suppl/10.1021/acsomega.8b03186/suppl_file/ao8b03186_si_001.pdf).

Homology Modeling of *Dt*Rha and Docking of Ligands {#sec4.7}
---------------------------------------------------

The structure of *Dt*Rha was used as a starting template, and loop 681--712, which was missing in the structure, was built using COOT. The resulting model was then prepared with AmberTools^[@ref36]^ and then equilibrated using the NAMD software^[@ref37]^ and AMBER-FB15 force field.^[@ref38]^ Docking of rhamnosylated substrates was done by first applying AM1-BCC charges on the ligand.^[@ref39]^ Then, the ligand was placed 10 Å away, facing the active site (according to PDB 3W5M and 3W5N). Then, the *Dt*Rha--substrate complex was formed using steered molecular dynamics at 100 K using the structural alignment of rhamnose in its binding pocket as the final orientation, according to published procedures.^[@ref29]^*Dt*Rha backbone was kept constrained during the whole procedure. Finally, protein--ligand complex models were equilibrated by releasing substrate constraints and applying several cycles of energy minimization (10,000 steps, steepest descent), followed by molecular dynamics (100 K, 1 ns). Final complex models were obtained by final energy minimization. All structural figures were drawn using PyMOL Molecular Graphics system 1.6 ([www.pymol.org](www.pymol.org)).

The Supporting Information is available free of charge on the [ACS Publications website](http://pubs.acs.org) at DOI: [10.1021/acsomega.8b03186](http://pubs.acs.org/doi/abs/10.1021/acsomega.8b03186).SDS-PAGE gel, chemical formulae of substrates, pH and *T* profiles, Michaelis--Menten plot, stability of *Dt*Rha, HPLC chromatograms, HMRS spectra, and data collection and refinement statistics for *Dt*Rha crystal structure ([PDF](http://pubs.acs.org/doi/suppl/10.1021/acsomega.8b03186/suppl_file/ao8b03186_si_001.pdf))
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